NCT03224650View on ClinicalTrials.gov

Validation of Novel Predictive Score for Patients With Spinal Metastases

CompletedOBSERVATIONAL
Enrollment

219

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

July 13, 2020

Study Completion Date

January 31, 2022

Conditions
Spinal Metastases
Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT03224650 - Validation of Novel Predictive Score for Patients With Spinal Metastases | Biotech Hunter | Biotech Hunter